Author Information
Dr. Marianna Kulka is affiliated with the Nanotechnology Research Council in Canada, located at 11421 Saskatchewan Drive NW, Edmonton, AB T6G2M9, Canada. Additionally, she is part of the Department of Medical Microbiology and Immunology at the University of Alberta, situated at the 6-020 Katz Group Center, Edmonton, AB T6G2E1, Canada.
Research Contributions
Dr. Marianna Kulka has made significant contributions in the fields of nanotechnology and immunology. Her research spans various topics, including the internalization of benzylisoquinoline alkaloids by bone marrow-derived mast cells, the design of ROS-reactive nanocarriers for controlled drug release, and the activation of human mast cells by prion-specific IgE. Her recent works also focus on the biological effects of sesquiterpene chemistry on inflammation, the effects of hybrid nanoparticles on mast cell functions, and the communication between mast cells and microglia in neurodegenerative diseases. Dr. Kulka's research is characterized by its interdisciplinary approach, combining principles of chemistry, biology, and nanotechnology to address complex biomedical challenges.
Aliases
Dr. Marianna Kulka is also known by several other names in academic circles, including M Kulka, M. Kulka, and Marianne Kulka.
Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
3246 |
| h-index |
25 |
| Paper Count |
127 |
